Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2025-12-25 @ 3:11 AM
NCT ID:
NCT03338205
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients (≥2 years and ≤ 18 years old)
Patients presenting in status asthmaticus:
* Patients with a CAS of greater than or equal to 10 on presentation that have received at least two (appropriately dosed based on weight) albuterol treatments prior to arrival
OR
* Patients with a CAS of greater than or equal to 10 that have not received treatment prior to arrival and after 1 hour of treatment per the severe asthma pathway do not have a decrease in CAS of greater than 2
OR
* Patients with a CAS above 6 but less than 10 as measured 1 hour after initiation of standard treatment per AU's moderate asthma pathway
Exclusion Criteria:
* Pregnancy
* Congestive Heart Failure or prior diagnosis of cardiovascular disease (congenital or acquired)
* Chronic lung disease outside of a previous diagnosis of Asthma
* Seizure disorder
* Liver disease
* History of hypertension greater than 95% for age
* Obstructive Sleep Apnea with AHI greater than 5
* History of allergic or serious reaction to Ketamine
* Significant history of psychiatric illness defined as any patient with a diagnosis of psychiatric illness meeting the Diagnostic and Statistical Manual of Mental Disorders V criteria (severe Autism)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT03338205
Study Brief:
Protocol Section:
NCT03338205